Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Squro 200 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Squro 200

Approved

STANDARD

Squro 200

Intas Pharmaceuticals Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5fb86f0a6c7d99d5
Company: Intas Pharmaceuticals Limited
Type: Standard

Approval Details

Approval Id: 5fb86f0a6c7d99d5
Drug Approval Philippines Name: Squro 200
Product Name: Squro 200
Registration Number: DRP-10612
Brand Name: Squro 200
Generic Name: Quetiapine (as fumarate)
Dosage Form: Film-Coated Sustained-Release Tablet
Dosage Strength: 200 mg
Manufacturer: Intas Pharmaceuticals Limited
Importer: Accord Healthcare Limited - Philippine Branch Office
Distributor: Accord Healthcare Limited - Philippine Branch Office
Company Detail Path: /organization/intas-pharmaceuticals-limited
Issuance Date: 26 October 2021
Expiry Date: 26 October 2026
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5fb86f0a6c7d99d5

Type

Standard

Back to Philippines FDA Approvals